跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Calcisaph - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Calcisaph
Approved
STANDARD
Calcisaph
Sapphire Lifesciences Pvt., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5657ee6f75911a65
Company
Sapphire Lifesciences Pvt., Ltd.
Type
Standard
Approval Details
Approval Id
5657ee6f75911a65
Drug Approval Philippines Name
Calcisaph
Product Name
Calcisaph
Registration Number
DRP-9095
Brand Name
Calcisaph
Generic Name
Calcium Carbonate
Dosage Form
Tablet
Dosage Strength
500 mg (equivalent to 200 mg elemental Calcium)
Manufacturer
Sapphire Lifesciences Pvt., Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
25 May 2025
Expiry Date
25 August 2031
Pharmacologic Category
Mineral/Antacid
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5657ee6f75911a65
Type
Standard
Back to Philippines FDA Approvals